TP53 gene mutations in plasma DNA of cancer patients

被引:0
|
作者
Silva, JM [1 ]
Gonzalez, R [1 ]
Dominguez, G [1 ]
Garcia, JM [1 ]
España, P [1 ]
Bonilla, F [1 ]
机构
[1] Clin Puerta de Hierro, Dept Med Oncol, Madrid 28035, Spain
来源
GENES CHROMOSOMES & CANCER | 1999年 / 24卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using different molecular techniques, DNA has been shown to be present in plasma of patients with several types of tumors. Mutations of TP53 are the most common genetic changes in human cancers. We investigated the presence of TP53 gene mutations in plasma DNA of breast and small cell lung cancer patients. Tumor and plasma DNA of 25 patients were studied by PCR-SSCP and direct sequencing, through exons 5, 6, 7, and 8, of TP53. Six cases of mutations in tumor DNA were observed that, in 3 cases (50%), were also identified in plasma of the same patients. Mutations of the TP53 gene are seen in plasma DNA of cancer patients, and may prove to be a useful new tool in the management of these patients. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:160 / 161
页数:2
相关论文
共 50 条
  • [31] TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients
    Pandey, Ritu
    Johnson, Nathan
    Cooke, Laurence
    Johnson, Benny
    Chen, Yuliang
    Pandey, Manjari
    Chandler, Jason
    Mahadevan, Daruka
    CANCERS, 2021, 13 (04) : 1 - 21
  • [32] KRAS, BRAF and TP53 mutations in Romanian colorectal cancer patients
    Murarasu, Daniela
    Puiu, Liliana
    Mihalcea, Corina
    Cinca, Sabin
    Simion, Laurentiu
    JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S92 - S92
  • [33] Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
    Alsner, J
    Yilmaz, M
    Guldberg, P
    Hansen, LL
    Overgaard, J
    CLINICAL CANCER RESEARCH, 2000, 6 (10) : 3923 - 3931
  • [34] Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
    J Alsner
    M Yilmaz
    P Guldberg
    LL Hansen
    J Overgaard
    Breast Cancer Research, 2 (Suppl 1)
  • [35] TP53 gene mutations as an independent marker for urinary bladder cancer progression
    Ecke, T. H.
    Sachs, M. D.
    Lenk, S. V.
    Miller, K.
    Schlechte, H. H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 44 - 44
  • [36] Time series analysis of TP53 gene mutations in recurrent vulvar cancer
    Kashofer, K.
    Winter, E.
    Reich, O.
    Hoefler, G.
    Regauer, S.
    VIRCHOWS ARCHIV, 2018, 473 : S33 - S33
  • [37] Mutations and polymorphisms in TP53 gene-an overview on the role in colorectal cancer
    Naccarati, A.
    Polakova, V.
    Pardini, B.
    Vodickova, L.
    Hemminki, K.
    Kumar, R.
    Vodicka, P.
    MUTAGENESIS, 2012, 27 (02) : 211 - 218
  • [38] Germline Mutations of TP53 Gene Among Children with Cancer from Russia
    Yasko, L.
    Kurnikova, M.
    Mersiyanova, I.
    Brilliantova, V.
    Raikina, E.
    Druy, A.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S511 - S511
  • [39] TP53 gene mutations as an independent marker for urinary bladder cancer progression
    Ecke, Thorsten H.
    Sachs, Markus D.
    Lenk, Severin V.
    Loening, Stefan A.
    Schlechte, Horst H.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 21 (05) : 655 - 661
  • [40] TP53 Gene Mutations in Russian Patients With Mantle Cell Lymphoma (MCL)
    Biderman, Bella
    Koroleva, Darya
    Severina, Natalya
    Gabeeva, Nelly
    Julhakyan, Hunan
    Zvonkov, Evgeniy
    Sudarikov, Andrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S460 - S460